The Global CAR T-Cell Therapy market is expected to grow at a CAGR of 56.2% from 2018 to 2026.

The key vendors mentioned are Mustang Bio, Inc., Celgene Corporation, Bluebird Bio, Inc., CARsgen Therapeutics, Ltd., Novartis International AG, Bellicum Pharmaceuticals, Inc., Pfizer, Inc, Eureka Therapeutics, Autolus, TILT Biotherapeutics, and Fortress Biotech.

Hyderabad, India - October 9, 2019 /MarketersMedia/ —

Chimeric Antigen Receptor (CAR) T Cell Therapy is a type of treatment in which patient T cells are changed in the laboratory to attack the cancer cells. In this therapy, T cells from patient body are isolated and inserted in the CAR gene so that the gene for the specific receptor binds to a certain protein on the patient’s cancer cells. CAR T-cell therapy uses patients own modified white blood cells to kill the cancer cells. CAR T-cell therapy is moreover a living drug and its benefits can last for many years. CAR T cell therapy is used in curing patients with breast cancer, pancreas cancer, colorectal cancer and various types of blood cancer. Factors such as technological advancement for advanced & reliable treatment for cancer, growing pharmaceutical industry, high prevalence of acute lymphoblastic lymphoma (ALL) and increase in the number of cell therapy clinical studies are fuelling the market growth. However, side-effects of CAR T-cell therapy and high cost of treatment are likely to hamper the market growth.

Access the complete report at: https://www.syngeneresearch.com/global-car-t-cell-therapy-market-analysis-2019-2/

Based on the application, diffuse large B-cell lymphoma is a cancer of B cells, a type of white blood cell responsible for producing antibodies. It is the most common type of non-Hodgkin lymphoma among adults. This cancer occurs primarily in older individuals, with a median age of diagnosis at approximately 70 years of age, though it can also occur in children and young adults in rare cases. DLBCL is an aggressive tumour which can arise in virtually any part of the body, and the first sign of this illness is typically the observation of a rapidly growing mass, sometimes associated with B symptoms of fever, weight loss, and night sweats.

Make an inquiry at: https://www.syngeneresearch.com/global-car-t-cell-therapy-market-analysis-2019-2/

Target Antigens Covered:
• CD20
• EGFRV III
• CD19
• HER2
• MESO
• CD22
• BCMA
• GD2
• CD30
• HER1
• CD33

Products Covered:
• Allogeneic
• Autologous

Therapies Covered:
• Axicabtagene Ciloleucel (Yescarta)
• Tisagenlecleucel (Kymriah)

Applications Covered:
• Chronic Lymphocytic Leukemia
• Diffuse Large B-Cell Lymphoma
• Multiple Myeloma
• Acute Lymphoblastic Leukemia
• Follicular Lymphoma
• Mantle Cell Lymphoma
• Glioblastoma
• Neuroblastoma
• Breast Cancer
• Sarcoma
• Acute Myeloid Leukemia
• Colorectal Cancer
• Pancreatic Cancer
• Hepatocellular Carcinoma
• Non-Hodgkin Leukemia
• Carcinoma

End Users Covered:
• Cancer Research Centers
• Hospitals
• Academic and Research Institutes
• Pharmaceutical Companies
• Biotechnology Companies
• Contract Research Organizations

Regions Covered:
• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

Learn more about Syngeneresearch here: https://www.syngeneresearch.com/about-syngene-research/

Key Questions Answered in this Report:
• How this market evolved since the year 2016
• Market size estimations, forecasts and CAGR for all the segments presented in the scope
• Key Market Developments and financials of the key players
• Opportunity Analysis for the new entrants
• SWOT Analysis of the key players
• Fastest growing markets analysed during the forecast period

Contact Info:
Name: Sadhana Shukla
Email: Send Email
Organization: Syngene Market Research Reports
Website: https://www.syngeneresearch.com/

Source URL: https://marketersmedia.com/the-global-car-t-cell-therapy-market-is-expected-to-grow-at-a-cagr-of-562-from-2018-to-2026/88926735

Source: MarketersMedia

Release ID: 88926735

More Press Releases

Queen Latifah to receive Harvard black culture award

Oct 22, 2019

CAMBRIDGE, Mass. — Music artist and actress Queen Latifah is among the honorees being recognized by Harvard University for their contributions to black history and culture. Harvard is set to award the W.E.B. Du Bois Medal to Queen Latifah and six other recipients on Tuesday, according to the Cambridge, Massachusetts, school's Hutchins Center for African and African American Research. Other honorees include poet and educator Elizabeth Alexander, Secretary of the Smithsonian Institution Lonnie Bunch III, poet Rita Dove, co-founder of Black Entertainment Television Sheila Johnson, artist Kerry James Marshall and Robert Smith, founder, chairman and chief executive of Vista Equity...

As NBA-China tweet rift continues, James enters spotlight

Oct 22, 2019

EL SEGUNDO, Calif. — LeBron James has stepped into the spotlight of the now-strained relationship between the NBA and China with his comments about the league executive who started the ongoing fallout with what James derided as a "misinformed" tweet. Politicians, human rights groups and ordinary fans on social media have criticized the outspoken superstar, questioning the motivation of James' comments. James spoke out Monday, his seven-minute session with reporters putting him squarely in the center of the ongoing international schism. Houston general manager Daryl Morey was "not really educated on the situation," James asserted, when he sent out that...

Trump calls for Spicer votes on 'Dancing with the Stars'

Oct 22, 2019

LOS ANGELES — President Donald Trump is trying to influence votes on ABC's "Dancing with the Stars." Trump on Monday tweeted that viewers should vote for former White House press secretary Sean Spicer. The president called Spicer a "good guy" and wrote "he has always been there for us!" Spicer tweeted his thanks with instructions on how viewers can cast votes. Spicer has been paired with professional dancer Lindsay Arnold as they compete for the mirror ball trophy. He says he's doing it "to have fun and make it a really good experience." Trump supporters have embraced Spicer, but opponents...

George Clooney calls Trump's quip on Kurds 'pretty shocking'

Oct 22, 2019

HELSINKI — George Clooney said on Thursday he was appalled U.S. President Donald Trump partly justified the decision to withdraw U.S. troops from Syria by stating Kurds "didn't help us with Normandy" during World War II. The politically active Hollywood actor, director and producer told a business seminar in Finland's capital that he found Trump's words from a day earlier "a pretty shocking statement." Clooney accused Washington of leaving the allies of U.S. forces in Syria to deal alone with Turkey's military offensive. "I'm horrified at the idea we would say that after having Kurds fight our battle for us...

Cuba Gooding Jr. faces new charge in NYC sex misconduct case

Oct 22, 2019

NEW YORK — Cuba Gooding Jr. learned on Thursday that he's facing a new undisclosed charge in his sexual misconduct case, a development that came as jury selection was set to begin for his trial. At a court hearing in Manhattan, Assistant District Attorney Jenna Long revealed the charge is contained in a sealed indictment against the Oscar-winning "Jerry Maguire" star. She told a judge that the indictment covers previous allegations as well as a "previously uncharged incident." Gooding, 51, now must be arraigned on the new indictment next week before a trial can begin. He and his lawyers left...

Broaden News

Reporter Pass is the only access you need to get into Hollywood. No matter it’s the red carpet event or backstage access, we’ve got you covered.

Award ShowsCelebrityPaparazziRoyaltyMoviesMusicTelevision Programs Press Releases